Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Current Deferred Revenue (2023 - 2025)

ASP Isotopes has reported Current Deferred Revenue over the past 3 years, most recently at $900000.0 for Q4 2025.

  • On a quarterly basis, Current Deferred Revenue changed 0.0% to $900000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $900000.0, a 0.0% change, with the full-year FY2025 number at $900000.0, changed 0.0% from a year prior.
  • Current Deferred Revenue reached $900000.0 in Q4 2025 per ASPI's latest filing, up from $882000.0 in the prior quarter.
  • The five-year high for Current Deferred Revenue was $900000.0 in Q4 2024, with the low at $882000.0 in Q4 2023.
  • The 3-year median for Current Deferred Revenue is $882000.0 (2023), against an average of $886000.0.
  • Peak YoY movement for Current Deferred Revenue: grew 2.04% in 2024, then changed 0.0% in 2025.
  • Tracing ASPI's Current Deferred Revenue over 3 years: stood at $882000.0 in 2023, then grew by 2.04% to $900000.0 in 2024, then changed by 0.0% to $900000.0 in 2025.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $900000.0, $882000.0, and $882000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.